Stage IVA Prostate Cancer AJCC v8 Recruiting Phase 2 Trials for Prednisone (DB00635)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04947254Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate CancerTreatment
NCT04734730Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate CancerTreatment